Chad Gassert
SVP - Corp. Dev. & Strategy at Ani Pharmaceuticals Inc (ANIP) since November 2021
Chad Gassert has filed 22 insider reports with the SEC since November 2021, as SVP - Corp. Dev. & Strategy at Ani Pharmaceuticals Inc (ANIP). In the last 12 months Chad Gassert sold $1.31M of stock on the open market. The latest filing, on March 2, 2026, reports grant or award and shares withheld for taxes or exercise price at Ani Pharmaceuticals Inc (ANIP).
- Filings
- 22
- Companies
- 1
- Bought on market
- $275K
- Sold on market
- $15.1M
Companies where Chad Gassert is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| SVP - Corp. Dev. & Strategysince November 2021 | 74,916 | $275K | $15.1M | $27.51 | $71.44+160% | Mar 2, 2026 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.
Every filing
- Feb 28, 2026ANIPSVP - CORP. DEV. & STRATEGY Gassert Chad was granted 11,116 shares and covered exercise/tax liability with 2,221 shares, increasing direct ownership by 13% to 74,916 unitsForm 4Grant or awardShares withheld for taxes or exercise price
- Feb 14, 2026ANIPSVP - CORP. DEV. & STRATEGY Gassert Chad covered exercise/tax liability with 3,325 shares, decreasing direct ownership by 5% to 66,021 unitsForm 4Shares withheld for taxes or exercise price
- Feb 11, 2026ANIPSVP - CORP. DEV. & STRATEGY Gassert Chad covered exercise/tax liability with 4,269 shares, decreasing direct ownership by 6% to 69,346 unitsForm 4Shares withheld for taxes or exercise price
- Nov 13, 2025-$1.31MANIPSVP - CORP. DEV. & STRATEGY Gassert Chad sold $1,312,435 worth of shares (14,736 units at $89.06)Form 4Open-market sale
- Aug 15, 2025-$1.74MANIPSVP - CORP. DEV. & STRATEGY Gassert Chad sold $1,739,400 worth of shares (20,000 units at $86.97)Form 4Open-market sale
- Feb 12, 2025ANIPSVP - CORP. DEV. & STRATEGY Gassert Chad was granted 23,936 shares, increasing direct ownership by 48% to 73,615 unitsForm 4Grant or award
- Jul 1, 2024-$1.27MANIPSVP - CORP. DEV. & STRATEGY Gassert Chad sold $1,268,800 worth of shares (20,000 units at $63.44)Form 4Open-market sale10b5-1 plan
- Jun 3, 2024-$1.29MANIPGassert Chad sold $1,288,200 worth of shares (20,000 units at $64.41)Form 4Open-market sale10b5-1 plan
- May 1, 2024-$1.33MANIPGassert Chad sold $1,332,400 worth of shares (20,000 units at $66.62)Form 4Open-market sale10b5-1 plan
- Apr 1, 2024-$1.35MANIPGassert Chad sold $1,345,000 worth of shares (20,000 units at $67.25)Form 4Open-market sale10b5-1 plan
- Mar 11, 2024-$1.32MANIPGassert Chad sold $1,316,200 worth of shares (20,000 units at $65.81)Form 4Open-market sale10b5-1 plan
- Feb 29, 2024ANIPGassert Chad covered exercise/tax liability with 1,635 shares, decreasing direct ownership by 3% to 49,679 unitsForm 4Shares withheld for taxes or exercise price
- Feb 14, 2024ANIPGassert Chad was granted 22,367 shares, increasing direct ownership by 77% to 51,314 unitsForm 4Grant or award
- Oct 2, 2023-$1.13MANIPGassert Chad sold $1,129,600 worth of shares (20,000 units at $56.48)Form 4Open-market sale10b5-1 plan
- Sep 1, 2023-$1.29MANIPSEC Form 4: Gassert Chad sold $1,294,000 worth of shares (20,000 units at $64.70)Form 4Open-market sale10b5-1 plan
- Aug 1, 2023-$1.02MANIPSEC Form 4: Gassert Chad sold $1,021,200 worth of shares (20,000 units at $51.06)Form 4Open-market sale10b5-1 plan
- Jul 3, 2023-$1.07MANIPSEC Form 4 filed by Gassert ChadForm 4Open-market sale10b5-1 plan
- Jun 22, 2023-$1.03MANIPSEC Form 4 filed by Gassert ChadForm 4Open-market sale10b5-1 plan
- Feb 28, 2023ANIPSEC Form 4 filed by Gassert ChadForm 4Grant or award
- Mar 21, 2022+$275KANIPSEC Form 4: Gassert Chad bought $275,086 worth of shares (10,000 units at $27.51)Form 4Open-market purchase
- Nov 19, 2021ANIPSEC Form 4: Gassert Chad was granted 383,226 sharesForm 4Grant or award
- Nov 19, 2021ANIPChad Gassert became an insiderForm 3New insider
Compare Chad Gassert with
- Chad Gassert vs Stephen P. Carey1 shared
- Chad Gassert vs Nikhil Lalwani1 shared
- Chad Gassert vs Jeanne Thoma1 shared
- Chad Gassert vs Meredith Cook1 shared
- Chad Gassert vs Henry O Gosebruch1 shared
- Chad Gassert vs Ori Gutwerg1 shared
Other insiders at the same companies
- Meredith CookANIP
- Stephen P. CareyANIP
- Nikhil LalwaniANIP
- Jeanne ThomaANIP
- Henry O GosebruchANIP
- Ori GutwergANIP
- Patrick D WalshANIP
- Renee P TannenbaumANIP
- Antonio R PeraANIP
- Matthew J LeonardANIP
- Thomas HaugheyANIP
- Thomas Andrew RowlandANIP
- Christopher MutzANIP
- Krista DavisANIP
- Muthusamy ShanmugamANIP
Questions about Chad Gassert
- What is Chad Gassert's role at Ani Pharmaceuticals Inc?
- Chad Gassert reports to the SEC as SVP - Corp. Dev. & Strategy at Ani Pharmaceuticals Inc (ANIP), according to the latest filing on March 2, 2026.
- How many shares does Chad Gassert own?
- After the latest filing that states it, Chad Gassert directly owned 74,916 shares of Ani Pharmaceuticals Inc (ANIP). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Chad Gassert bought or sold stock recently?
- The most recent open-market purchase was on March 21, 2022: bought 10,000 shares of Ani Pharmaceuticals Inc (ANIP) for $275K at an average of $27.51. The most recent open-market sale was on November 13, 2025: sold 14,736 shares of Ani Pharmaceuticals Inc (ANIP) for $1.31M at an average of $89.06.
- How do I get alerts when Chad Gassert files?
- Follow Chad Gassert on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Chad Gassert (SEC CIK 0001871002). Totals count each trade once, skipping amendments whose original is on file, from Nov 23, 2021 on. View on SEC EDGAR